Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 27.19%17.75B | ---- | 8.53%28.42B | ---- | -7.59%13.95B | ---- | -9.55%26.19B | ---- | -1.97%15.1B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -40.32%-1.49B | ---- | -99.59%-4.14B | ---- | -5.00%-1.06B | ---- | -39.12%-2.07B | ---- | -23.53%-1.01B |
| Interest expense - adjustment | ---- | -7.77%3.05B | ---- | 6.02%6.62B | ---- | 4.88%3.31B | ---- | -2.08%6.25B | ---- | -5.32%3.15B |
| Attributable subsidiary (profit) loss | ---- | -48.85%-325.3M | ---- | 81.67%-117.57M | ---- | 40.13%-218.54M | ---- | 4.74%-641.46M | ---- | -259.09%-365.03M |
| Impairment and provisions: | ---- | 13.82%-298.34M | ---- | -169.26%-960.04M | ---- | -190.29%-346.17M | ---- | -93.76%-356.55M | ---- | 240.38%383.39M |
| -Other impairments and provisions | ---- | 13.82%-298.34M | ---- | -169.26%-960.04M | ---- | -190.29%-346.17M | ---- | -93.76%-356.55M | ---- | 240.38%383.39M |
| Revaluation surplus: | ---- | 149.67%1.52B | ---- | 268.55%6.02B | ---- | -79.09%-3.06B | ---- | -126.16%-3.57B | ---- | 16.32%-1.71B |
| -Other fair value changes | ---- | 149.67%1.52B | ---- | 268.55%6.02B | ---- | -79.09%-3.06B | ---- | -126.16%-3.57B | ---- | 16.32%-1.71B |
| Asset sale loss (gain): | ---- | 55.10%-752.94M | ---- | -95.35%-2.14B | ---- | -455.49%-1.68B | ---- | -294.11%-1.1B | ---- | -60.12%-301.85M |
| -Available for sale investment sale loss (gain) | ---- | 52.86%-782.98M | ---- | -95.98%-1.92B | ---- | -466.50%-1.66B | ---- | -282.15%-980.54M | ---- | -57.97%-293.19M |
| -Loss (gain) from sale of subsidiary company | ---- | 316.01%32.23M | ---- | 87.13%-14.88M | ---- | -119.38%-14.92M | ---- | -456.16%-115.6M | ---- | -239.22%-6.8M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -139.21%-2.18M | ---- | -32,447.87%-206.03M | ---- | 50.89%-913K | ---- | 31.49%-633K | ---- | 76.17%-1.86M |
| Depreciation and amortization: | ---- | 0.68%1.05B | ---- | 7.91%2.12B | ---- | 10.09%1.05B | ---- | 13.24%1.97B | ---- | 13.50%950.85M |
| -Depreciation | ---- | -1.34%847.31M | ---- | 10.62%1.73B | ---- | 17.30%858.81M | ---- | 15.97%1.57B | ---- | 12.51%732.14M |
| -Other depreciation and amortization | ---- | 9.89%206.54M | ---- | -2.62%392.65M | ---- | -14.06%187.95M | ---- | 3.73%403.22M | ---- | 16.97%218.71M |
| Operating profit before the change of operating capital | ---- | 71.72%20.5B | ---- | 34.40%35.83B | ---- | -26.28%11.94B | ---- | -44.58%26.66B | ---- | -3.94%16.19B |
| Change of operating capital | ||||||||||
| Financial assets at fair value (increase)decrease | ---- | -244.32%-37.79B | ---- | 30.33%-61.35B | ---- | 77.33%-10.97B | ---- | -803.15%-88.07B | ---- | -267.47%-48.41B |
| Special items for working capital changes | ---- | -84.24%6.57B | ---- | 274.18%126.77B | ---- | 45.52%41.68B | ---- | 34.05%33.88B | ---- | -59.01%28.64B |
| Cash from business operations | ---- | -125.13%-10.72B | ---- | 467.73%101.24B | ---- | 1,292.06%42.64B | ---- | -143.27%-27.53B | ---- | -104.86%-3.58B |
| Other taxs | ---- | -51.03%-3.12B | ---- | 17.87%-5.42B | ---- | 55.43%-2.07B | ---- | 21.07%-6.6B | ---- | -4.85%-4.64B |
| Adjustment items of business operations | -50.53%56.2B | ---- | -175.69%-53.36B | ---- | 309.25%113.61B | ---- | 3,296.98%70.5B | ---- | -187.93%-54.3B | ---- |
| Net cash from operations | -50.53%56.2B | -134.11%-13.84B | -175.69%-53.36B | 380.73%95.82B | 309.25%113.61B | 593.78%40.58B | 3,296.98%70.5B | -161.77%-34.13B | -187.93%-54.3B | -111.89%-8.22B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 105.55%197.05M | ---- | ---- | ---- | -3.80%95.86M | ---- | ---- | ---- | -39.45%99.65M | ---- |
| Purchase of fixed assets | -18.01%-801.66M | -18.39%-537.55M | 10.33%-182.9M | 18.13%-1.29B | 27.18%-679.33M | 23.10%-454.06M | 44.94%-203.98M | -21.15%-1.58B | -12.60%-932.88M | -23.59%-590.49M |
| Recovery of cash from investments | 31,468.58%38.42B | ---- | 36,963.25%26.76B | ---- | -99.19%121.7M | ---- | -90.68%72.19M | ---- | -50.48%14.94B | ---- |
| Cash on investment | 91.59%-3.23B | 176.11%32.31B | ---- | -67.38%164.98M | -3,701.48%-38.47B | -6,597.56%-42.45B | -1,849,862.17%-36.54B | 72.10%505.77M | -207.57%-1.01B | -96.30%653.35M |
| Other items in the investment business | -428.35%-48.26M | 391.91%40.42M | -1,132.86%-53.76M | -327.09%-73.14B | 113.51%14.7M | 107.02%8.22M | 125.31%5.2M | -7,940.59%-17.12B | -282.59%-108.77M | -458.46%-117.11M |
| Net cash from investment operations | 188.74%34.53B | 174.16%31.81B | 172.33%26.52B | -308.09%-74.26B | -399.72%-38.92B | -78,982.35%-42.9B | -7,550.58%-36.66B | -2,198.49%-18.2B | -55.58%12.98B | -100.32%-54.24M |
| Net cash before financing | 21.47%90.74B | 874.27%17.97B | -179.34%-26.84B | 141.19%21.56B | 280.82%74.7B | 71.94%-2.32B | 2,075.08%33.83B | -196.08%-52.33B | -145.41%-41.31B | -109.58%-8.27B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 131.40%202.4B | 184.93%124.25B | 127.50%49.01B | 17.12%126.11B | 3.87%87.47B | -29.11%43.61B | -19.93%21.55B | 956.19%107.67B | 338.15%84.21B | 310.16%61.51B |
| Refund | -51.71%-380.81B | -66.23%-240.12B | -41.86%-100.01B | -34.03%-377.21B | -11.81%-251.01B | -7.39%-144.45B | -35.61%-70.5B | -111.29%-281.44B | -113.50%-224.5B | -84.73%-134.51B |
| Issuance of bonds | 53.30%221.07B | 14.75%101.82B | 9.03%46.46B | 7.39%255.2B | -13.92%144.2B | -12.63%88.73B | -15.65%42.61B | 236.04%237.64B | 227.06%167.53B | 193.85%101.55B |
| Dividends paid - financing | 20.27%-10.35B | -12.28%-4.29B | -24.96%-2.32B | -29.81%-18.56B | 3.75%-12.98B | 4.42%-3.82B | -3.49%-1.86B | 7.86%-14.3B | 4.56%-13.48B | -0.20%-4B |
| Absorb investment income | -55.56%4B | ---- | -57.14%3B | ---- | --9B | ---- | --7B | ---- | ---- | ---- |
| Other items of the financing business | -43.55%-927.74M | 71.65%-151.65M | -53.24%-300.23M | 30.83%-895.42M | 35.10%-646.28M | 19.75%-534.86M | -76.25%-195.92M | -7.06%-1.29B | -608.10%-995.81M | -2,805.91%-666.52M |
| Net cash from financing operations | 247.62%35.38B | -12.30%-18.49B | -198.16%-4.16B | -131.82%-15.36B | -287.97%-23.97B | -168.92%-16.47B | -105.93%-1.39B | 215.34%48.28B | 168.97%12.75B | 36,862.95%23.9B |
| Effect of rate | -85.29%-359.59M | 67.69%-52.83M | 184.07%105.91M | -38.54%245.09M | -175.81%-194.07M | -123.13%-163.54M | 65.59%-125.98M | -28.36%398.77M | -87.55%255.99M | 338.23%707.15M |
| Net Cash | 148.61%126.12B | 97.21%-523.84M | -195.56%-31B | 252.98%6.19B | 277.62%50.73B | -220.26%-18.79B | 48.68%32.44B | -132.12%-4.05B | -139.40%-28.56B | -81.89%15.62B |
| Begining period cash | 24.57%421.78B | 6.47%106.02B | 24.57%421.78B | -3.54%99.58B | -2.97%338.6B | -3.54%99.58B | -2.97%338.6B | 14.62%103.23B | 11.66%348.95B | 14.62%103.23B |
| Cash at the end | 40.71%547.54B | 30.78%105.44B | 5.39%390.89B | 6.47%106.02B | 21.36%389.13B | -32.57%80.62B | 0.14%370.91B | -3.54%99.58B | -17.16%320.65B | -32.08%119.56B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.